| Symbol |
Name |
|
ABAT
|
4-aminobutyrate aminotransferase
|
|
ADAM19
|
ADAM metallopeptidase domain 19
|
|
ADAMDEC1
|
ADAM-like, decysin 1
|
|
AGRN
|
agrin
|
|
AIRE
|
autoimmune regulator
|
|
AKAP12
|
A kinase (PRKA) anchor protein 12
|
|
ALCAM
|
activated leukocyte cell adhesion molecule
|
|
ALDH2
|
aldehyde dehydrogenase 2 family (mitochondrial)
|
|
APOBEC3F
|
apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3F
|
|
APOBEC3G
|
apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3G
|
|
APOC1
|
apolipoprotein C-I
|
|
APOE
|
apolipoprotein E
|
|
ARNT2
|
aryl-hydrocarbon receptor nuclear translocator 2
|
|
ATF7IP2
|
activating transcription factor 7 interacting protein 2
|
|
ATP13A2
|
ATPase type 13A2
|
|
BCL6
|
B-cell CLL/lymphoma 6
|
|
BIRC3
|
baculoviral IAP repeat containing 3
|
|
BLK
|
BLK proto-oncogene, Src family tyrosine kinase
|
|
BMP2K
|
BMP2 inducible kinase
|
|
BTN2A2
|
butyrophilin, subfamily 2, member A2
|
|
BUB1
|
BUB1 mitotic checkpoint serine/threonine kinase
|
|
C3ORF14
|
chromosome 3 open reading frame 14
|
|
CACNG3
|
calcium channel, voltage-dependent, gamma subunit 3
|
|
CAPG
|
capping protein (actin filament), gelsolin-like
|
|
CAPN3
|
calpain 3, (p94)
|
|
CCL19
|
chemokine (C-C motif) ligand 19
|
|
CCNB1
|
cyclin B1
|
|
CCNF
|
cyclin F
|
|
CCNG2
|
cyclin G2
|
|
CCR7
|
chemokine (C-C motif) receptor 7
|
|
CD1E
|
CD1e molecule
|
|
CD200
|
CD200 molecule
|
|
CD86
|
CD86 molecule
|
|
CDC20
|
cell division cycle 20
|
|
CDC42EP4
|
CDC42 effector protein (Rho GTPase binding) 4
|
|
CDH1
|
cadherin 1, type 1, E-cadherin (epithelial)
|
|
CDH11
|
cadherin 11, type 2, OB-cadherin (osteoblast)
|
|
CDKN1A
|
cyclin-dependent kinase inhibitor 1A (p21, Cip1)
|
|
CEL
|
carboxyl ester lipase
|
|
CELSR1
|
cadherin, EGF LAG seven-pass G-type receptor 1
|
|
CENPF
|
centromere protein F, 350/400kDa
|
|
CHI3L1
|
chitinase 3-like 1 (cartilage glycoprotein-39)
|
|
CHRNA1
|
cholinergic receptor, nicotinic, alpha 1 (muscle)
|
|
CLDN3
|
claudin 3
|
|
CLEC7A
|
C-type lectin domain family 7, member A
|
|
CLU
|
clusterin
|
|
CNTNAP2
|
contactin associated protein-like 2
|
|
COL9A2
|
collagen, type IX, alpha 2
|
|
CRYBB1
|
crystallin, beta B1
|
|
CSAG2
|
CSAG family, member 2
|
|
CSF2RB
|
colony stimulating factor 2 receptor, beta, low-affinity (granulocyte-macrophage)
|
|
CST7
|
cystatin F (leukocystatin)
|
|
CSTA
|
cystatin A (stefin A)
|
|
CTSH
|
cathepsin H
|
|
CTSS
|
cathepsin S
|
|
CUL7
|
cullin 7
|
|
CX3CR1
|
chemokine (C-X3-C motif) receptor 1
|
|
CXCL10
|
chemokine (C-X-C motif) ligand 10
|
|
CXCL13
|
chemokine (C-X-C motif) ligand 13
|
|
CYP1B1
|
cytochrome P450, family 1, subfamily B, polypeptide 1
|
|
CYP3A5
|
cytochrome P450, family 3, subfamily A, polypeptide 5
|
|
DAPP1
|
dual adaptor of phosphotyrosine and 3-phosphoinositides
|
|
DAZL
|
deleted in azoospermia-like
|
|
DDAH2
|
dimethylarginine dimethylaminohydrolase 2
|
|
DDX43
|
DEAD (Asp-Glu-Ala-Asp) box polypeptide 43
|
|
DDX58
|
DEAD (Asp-Glu-Ala-Asp) box polypeptide 58
|
|
DHX8
|
DEAH (Asp-Glu-Ala-His) box polypeptide 8
|
|
DNMT3L
|
DNA (cytosine-5-)-methyltransferase 3-like
|
|
DOCK10
|
dedicator of cytokinesis 10
|
|
DOK4
|
docking protein 4
|
|
DPEP3
|
dipeptidase 3
|
|
EBI3
|
Epstein-Barr virus induced 3
|
|
ENPP2
|
ectonucleotide pyrophosphatase/phosphodiesterase 2
|
|
EPHX2
|
epoxide hydrolase 2, cytoplasmic
|
|
FAM49A
|
family with sequence similarity 49, member A
|
|
FBN1
|
fibrillin 1
|
|
FKBP5
|
FK506 binding protein 5
|
|
FOXM1
|
forkhead box M1
|
|
FSCN1
|
fascin actin-bundling protein 1
|
|
FUT7
|
fucosyltransferase 7 (alpha (1,3) fucosyltransferase)
|
|
GATA3
|
GATA binding protein 3
|
|
GBP1
|
guanylate binding protein 1, interferon-inducible
|
|
GCNT3
|
glucosaminyl (N-acetyl) transferase 3, mucin type
|
|
GPC4
|
glypican 4
|
|
GPM6B
|
glycoprotein M6B
|
|
GPNMB
|
glycoprotein (transmembrane) nmb
|
|
GPSM2
|
G-protein signaling modulator 2
|
|
HCK
|
HCK proto-oncogene, Src family tyrosine kinase
|
|
HERC6
|
HECT and RLD domain containing E3 ubiquitin protein ligase family member 6
|
|
HIST1H2AE
|
histone cluster 1, H2ae
|
|
HIST1H2AG
|
histone cluster 1, H2ag
|
|
HIST1H2BG
|
histone cluster 1, H2bg
|
|
HIST1H3D
|
histone cluster 1, H3d
|
|
HLA-DMA
|
major histocompatibility complex, class II, DM alpha
|
|
HLA-DMB
|
major histocompatibility complex, class II, DM beta
|
|
HLA-DOB
|
major histocompatibility complex, class II, DO beta
|
|
HLA-DPA1
|
major histocompatibility complex, class II, DP alpha 1
|
|
HLA-DPB1
|
major histocompatibility complex, class II, DP beta 1
|
|
HLA-DQA1
|
major histocompatibility complex, class II, DQ alpha 1
|
|
HLA-DQA2
|
major histocompatibility complex, class II, DQ alpha 2
|
|
HLA-DQB1
|
major histocompatibility complex, class II, DQ beta 1
|
|
HLA-DRA
|
major histocompatibility complex, class II, DR alpha
|
|
HLA-DRB1
|
major histocompatibility complex, class II, DR beta 1
|
|
HLA-DRB4
|
major histocompatibility complex, class II, DR beta 4
|
|
HLA-DRB6
|
major histocompatibility complex, class II, DR beta 6 (pseudogene)
|
|
HNMT
|
histamine N-methyltransferase
|
|
HSD17B1
|
hydroxysteroid (17-beta) dehydrogenase 1
|
|
HSPA1A
|
heat shock 70kDa protein 1A
|
|
ICAM1
|
intercellular adhesion molecule 1
|
|
ID1
|
inhibitor of DNA binding 1, dominant negative helix-loop-helix protein
|
|
IDH2
|
isocitrate dehydrogenase 2 (NADP+), mitochondrial
|
|
IER3
|
immediate early response 3
|
|
IFI27
|
interferon, alpha-inducible protein 27
|
|
IFI44
|
interferon-induced protein 44
|
|
IFI44L
|
interferon-induced protein 44-like
|
|
IFIH1
|
interferon induced with helicase C domain 1
|
|
IFIT1
|
interferon-induced protein with tetratricopeptide repeats 1
|
|
IFIT3
|
interferon-induced protein with tetratricopeptide repeats 3
|
|
IFIT5
|
interferon-induced protein with tetratricopeptide repeats 5
|
|
IFITM1
|
interferon induced transmembrane protein 1
|
|
IGFBP3
|
insulin-like growth factor binding protein 3
|
|
IGFBP4
|
insulin-like growth factor binding protein 4
|
|
IGHA1
|
immunoglobulin heavy constant alpha 1
|
|
IL13RA1
|
interleukin 13 receptor, alpha 1
|
|
IL15
|
interleukin 15
|
|
IL1R2
|
interleukin 1 receptor, type II
|
|
IL32
|
interleukin 32
|
|
IL3RA
|
interleukin 3 receptor, alpha (low affinity)
|
|
IL6R
|
interleukin 6 receptor
|
|
IQSEC3
|
IQ motif and Sec7 domain 3
|
|
IRS2
|
insulin receptor substrate 2
|
|
ISG20
|
interferon stimulated exonuclease gene 20kDa
|
|
KCNN2
|
potassium channel, calcium activated intermediate/small conductance subfamily N alpha, member 2
|
|
KLF4
|
Kruppel-like factor 4 (gut)
|
|
KRT7
|
keratin 7, type II
|
|
KYNU
|
kynureninase
|
|
L1CAM
|
L1 cell adhesion molecule
|
|
LAMC2
|
laminin, gamma 2
|
|
LAMP3
|
lysosomal-associated membrane protein 3
|
|
LCP1
|
lymphocyte cytosolic protein 1 (L-plastin)
|
|
LDLR
|
low density lipoprotein receptor
|
|
LOR
|
loricrin
|
|
LPXN
|
leupaxin
|
|
LRFN4
|
leucine rich repeat and fibronectin type III domain containing 4
|
|
LSP1
|
lymphocyte-specific protein 1
|
|
MAFB
|
v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog B
|
|
MAGEA12
|
melanoma antigen family A12
|
|
MAGEA3
|
melanoma antigen family A3
|
|
MAGEA4
|
melanoma antigen family A4
|
|
MAGEA6
|
melanoma antigen family A6
|
|
MAGEA9
|
melanoma antigen family A9
|
|
MAGEB1
|
melanoma antigen family B1
|
|
MAGEC1
|
melanoma antigen family C1
|
|
MAP3K6
|
mitogen-activated protein kinase kinase kinase 6
|
|
MAP3K8
|
mitogen-activated protein kinase kinase kinase 8
|
|
MBNL2
|
muscleblind-like splicing regulator 2
|
|
MCAM
|
melanoma cell adhesion molecule
|
|
MICAL1
|
microtubule associated monooxygenase, calponin and LIM domain containing 1
|
|
MMP9
|
matrix metallopeptidase 9
|
|
MSR1
|
macrophage scavenger receptor 1
|
|
MUC1
|
mucin 1, cell surface associated
|
|
MX1
|
MX dynamin-like GTPase 1
|
|
MYO9B
|
myosin IXB
|
|
NADSYN1
|
NAD synthetase 1
|
|
NCF1
|
neutrophil cytosolic factor 1
|
|
NCF2
|
neutrophil cytosolic factor 2
|
|
NCF4
|
neutrophil cytosolic factor 4, 40kDa
|
|
NCR2
|
natural cytotoxicity triggering receptor 2
|
|
NQO1
|
NAD(P)H dehydrogenase, quinone 1
|
|
NR4A3
|
nuclear receptor subfamily 4, group A, member 3
|
|
NRXN1
|
neurexin 1
|
|
OCA2
|
oculocutaneous albinism II
|
|
OLFML2B
|
olfactomedin-like 2B
|
|
PACSIN2
|
protein kinase C and casein kinase substrate in neurons 2
|
|
PAEP
|
progestagen-associated endometrial protein
|
|
PDE4DIP
|
phosphodiesterase 4D interacting protein
|
|
PECAM1
|
platelet/endothelial cell adhesion molecule 1
|
|
PHLDA2
|
pleckstrin homology-like domain, family A, member 2
|
|
PIK3CD
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit delta
|
|
PIP5K1A
|
phosphatidylinositol-4-phosphate 5-kinase, type I, alpha
|
|
PLA2G4C
|
phospholipase A2, group IVC (cytosolic, calcium-independent)
|
|
PLEK
|
pleckstrin
|
|
PLK1
|
polo-like kinase 1
|
|
PMAIP1
|
phorbol-12-myristate-13-acetate-induced protein 1
|
|
PML
|
promyelocytic leukemia
|
|
PPP1R16B
|
protein phosphatase 1, regulatory subunit 16B
|
|
PRAME
|
preferentially expressed antigen in melanoma
|
|
PRF1
|
perforin 1 (pore forming protein)
|
|
PRSS2
|
protease, serine, 2 (trypsin 2)
|
|
PTGER4
|
prostaglandin E receptor 4 (subtype EP4)
|
|
PYY
|
peptide YY
|
|
RAB13
|
RAB13, member RAS oncogene family
|
|
RAB9A
|
RAB9A, member RAS oncogene family
|
|
RASSF2
|
Ras association (RalGDS/AF-6) domain family member 2
|
|
REL
|
v-rel avian reticuloendotheliosis viral oncogene homolog
|
|
RELN
|
reelin
|
|
RGS1
|
regulator of G-protein signaling 1
|
|
RGS13
|
regulator of G-protein signaling 13
|
|
RPS2
|
ribosomal protein S2
|
|
S100A13
|
S100 calcium binding protein A13
|
|
S100A4
|
S100 calcium binding protein A4
|
|
S100A6
|
S100 calcium binding protein A6
|
|
S100P
|
S100 calcium binding protein P
|
|
SAMSN1
|
SAM domain, SH3 domain and nuclear localization signals 1
|
|
SEPT9
|
septin 9
|
|
SERPINF1
|
serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 1
|
|
SLAMF7
|
SLAM family member 7
|
|
SMARCA1
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 1
|
|
SNN
|
stannin
|
|
SOCS1
|
suppressor of cytokine signaling 1
|
|
SOCS3
|
suppressor of cytokine signaling 3
|
|
SPARC
|
secreted protein, acidic, cysteine-rich (osteonectin)
|
|
SPIB
|
Spi-B transcription factor (Spi-1/PU.1 related)
|
|
SSTR2
|
somatostatin receptor 2
|
|
SSX1
|
synovial sarcoma, X breakpoint 1
|
|
SSX2
|
synovial sarcoma, X breakpoint 2
|
|
SSX3
|
synovial sarcoma, X breakpoint 3
|
|
SSX4
|
synovial sarcoma, X breakpoint 4
|
|
ST8SIA1
|
ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 1
|
|
STAT1
|
signal transducer and activator of transcription 1, 91kDa
|
|
SURF2
|
surfeit 2
|
|
SYNPO
|
synaptopodin
|
|
TANK
|
TRAF family member-associated NFKB activator
|
|
TBRG4
|
transforming growth factor beta regulator 4
|
|
TBX3
|
T-box 3
|
|
TFF2
|
trefoil factor 2
|
|
TFPI
|
tissue factor pathway inhibitor (lipoprotein-associated coagulation inhibitor)
|
|
TFPT
|
TCF3 (E2A) fusion partner (in childhood Leukemia)
|
|
TKTL1
|
transketolase-like 1
|
|
TNFAIP2
|
tumor necrosis factor, alpha-induced protein 2
|
|
TNFAIP6
|
tumor necrosis factor, alpha-induced protein 6
|
|
TNFRSF11A
|
tumor necrosis factor receptor superfamily, member 11a, NFKB activator
|
|
TNFRSF1B
|
tumor necrosis factor receptor superfamily, member 1B
|
|
TNFRSF25
|
tumor necrosis factor receptor superfamily, member 25
|
|
TNFRSF4
|
tumor necrosis factor receptor superfamily, member 4
|
|
TNFRSF9
|
tumor necrosis factor receptor superfamily, member 9
|
|
TOP2A
|
topoisomerase (DNA) II alpha 170kDa
|
|
TRIM22
|
tripartite motif containing 22
|
|
TRIP6
|
thyroid hormone receptor interactor 6
|
|
TSPAN15
|
tetraspanin 15
|
|
UBD
|
ubiquitin D
|
|
UPB1
|
ureidopropionase, beta
|
|
USP18
|
ubiquitin specific peptidase 18
|
|
VAMP8
|
vesicle-associated membrane protein 8
|
|
VCAM1
|
vascular cell adhesion molecule 1
|
|
VCX
|
variable charge, X-linked
|
|
XIST
|
X inactive specific transcript (non-protein coding)
|
|
ZSWIM8
|
zinc finger, SWIM-type containing 8
|